


The fund aims to provide income and some capital growth over the longer term by investing predominately in the shares of companies listed on European stock markets, excluding the UK.
| Name | % Net Assets | 
|---|---|
| Sanofi | 3.2% | 
| Swedish Match | 3.1% | 
| Nestle | 2.9% | 
| Zurich Insurance Group | 2.8% | 
| Anheuser-Busch InBev NV | 2.8% | 
| Wartsila B | 2.7% | 
| Roche Holdings | 2.6% | 
| Swiss Re Ltd | 2.5% | 
| Unilever | 2.3% | 
| ENI | 2.3% | 
| Key | % Net Assets | 
|---|---|
| 3.2% | |
| 3.1% | |
| 2.9% | |
| 2.8% | |
| 88% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 236.00p | 
| Currency | GBP | 
| Change | 0.90p | 
| % | 0.38% | 
| YTD change | 24.60p | 
| YTD % | 11.64% | 
| Fund Inception | 03/04/2009 | 
|---|---|
| Fund Manager | n/a | 
| TER | 0.86 (31-Dec-2010) | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 4.00% | 
| Annual Mang't | 0.75% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research